(Q35096221)

6 August 2017

1 reference

title

Chromosomal translocation products engender new intracellular therapeutic technologies (English)

1 reference

6 August 2017

Terence H Rabbitts

1

0 references

author name string

Martin R Stocks

series ordinal

2

1 reference

PubMed ID

12669051

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

383-386

1 reference

6 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0403-383

6 August 2017

0 references

cites work

Chromosomal translocations in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Design and selection of novel Cys2His2 zinc finger proteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Regulation of gene expression by small molecules

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Masked antisense: a molecular configuration for discriminating similar RNA targets

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

RNA interference: advances and questions

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

CML vaccines as a paradigm of the specific immunotherapy of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Signal transduction inhibition: results from phase I clinical trials in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

The selection of intracellular antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Selection of genetic agents from random peptide aptamer expression libraries

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Transgenic models of tumor development.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Intercellular trafficking and protein delivery by a herpesvirus structural protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

TAT-mediated protein transduction into mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Transcription factors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0403-383

7 January 2021

Identifiers

DOI

10.1038/NM0403-383

1 reference

PubMed ID

12669051

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12669051